Gene expression in breast cancer-Reference-Cited by-同舟云学术

Gene expression in breast cancer

Published:2006-04 Issue:2 Volume:7 Page:123-128
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Kaklamani Virginia G.,Gradishar William J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11864-006-0047-0.pdf

Reference17 articles.

1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687–1717.

2. Esteban JM, Baker JB, Cronin M, et al.: Tumor gene expression and prognosis in breast cancer: multi-gene RT-PCR assay of paraffin-embedded tissue. Proc Am Soc Clin Oncol 2003, 22:850.

3. Fisher B, Costantino J, Redmond C, et al.: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989, 320:479–484.

4. Perou CM, Sorlie T, Eisen MB, et al.: Molecular portraits of human breast tumours. Nature 2000, 406:747–752. This is the first report on tissue microarrays in breast cancer and the occurrence of different subtypes.

5. Sorlie T, Perou CM, Tibshirani R, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869–10874. In this article, the authors further subclassify breast cancers into different subtypes according to tissue microarray data.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of response to CDK4/6 inhibitors in the real-world setting;npj Precision Oncology;2023-09-13

2. Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis;Health Technol Assess;2013-10

3. LBoost: A Boosting Algorithm with Application for Epistasis Discovery;PLoS ONE;2012-11-08

4. Pharmacogenetics in Cancer;Pharmacogenetics and Individualized Therapy;2012-08-08

5. Approaches for Developing Novel Microtubule Targeting Agents (MTAs) for Therapeutic Exploitation;Current Pharmaceutical Design;2012-05-01